July 29, 2016

RV Systolic Pressure Shapes Survival in Mitral Regurgitation

Large study carries implications for timing of surgical repair

mitral valve regurgitation

Elevated right ventricular systolic pressure (RVSP) is independently associated with worse long-term survival in patients with primary mitral regurgitation (MR) and preserved left ventricular ejection fraction (LVEF), a large observational cohort study has shown. The study’s findings suggest that RVSP may play a role in guiding the timing of surgical intervention for patients with primary MR.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“In patients with severe mitral regurgitation who have minimal or no symptoms, it’s often a challenge to time surgery based on LVEF alone,” says corresponding author Milind Desai, MD, a cardiologist in Cleveland Clinic’s Section of Cardiovascular Imaging and Professor of Medicine at Cleveland Clinic Lerner College of Medicine. “We designed our study to determine whether baseline resting RVSP provides incremental prognostic usefulness in a large contemporary group of patients with significant primary mitral regurgitation and preserved LVEF.”

Study design and key results

The study, published in the June 28, 2016, issue of Journal of the American College of Cardiology, retrospectively analyzed data on all patients with primary myxomatous MR evaluated at Cleveland Clinic between 2005 and 2008. Of these patients, 1,318 met the primary inclusion criteria of having an initial resting echocardiogram demonstrating ≥ 3+ primary MR and an LVEF ≥ 60 percent.

These patients’ mean Society of Thoracis Surgeons (STS) score was 3.98 ± 1 percent. Eighty-five percent were in New York Heart Association (NYHA) functional class I or II; 18 percent had atrial fibrillation. Overall, 86 percent of the cohort underwent mitral valve surgery during the study’s follow-up period, typically soon after the baseline echocardiogram (median of five days).

Advertisement

At mean follow-up of 7.1 ± 2.0 years, the study’s primary outcome of death from any cause occurred in 130 patients (10 percent). Multivariable survival analysis for the primary outcome revealed the following key findings:

  • Higher baseline RVSP was associated with higher long-term mortality, with a 10 mm Hg increase in RVSP conferring a hazard ratio of 1.23 (95% CI, 1.12 to 1.36) (P < .01).
  • The RVSP threshold that appeared to distinguish between higher versus lower risk of future death was approximately 35 mm Hg — substantially lower than the 50 mm Hg threshold previously believed to confer increased risk.
  • Mitral valve surgery (as a time-dependent covariate) was highly associated with improved long-term survival (P < .001).
  • Adding RVSP to the STS score significantly improved patients’ reclassification for long-term mortality risk (P < .001).

Adding incremental prognostic value

“This study shows that, in addition to established risk factors, a higher baseline resting RVSP is significantly and independently associated with shorter long-term survival in patients with significant primary regurgitation and preserved LVEF,” says Dr. Desai. He identifies previously established risk factors as age, coronary artery disease, atrial fibrillation, NYHA class and LV dimensions.

“In addition to showing that mitral valve surgery is associated with long-term freedom from death, we found that adding baseline RVSP and mitral valve surgery provides incremental prognostic value to standard clinical predictors,” he adds.

Advertisement

Potential practice implications

Dr. Desai observes that this new analysis is much larger than previous studies of this issue, with much longer follow-up. He says it’s also notable because its patients, 85 percent of whom where in NYHA classes I or II, reflect “a much less sick population, in whom indirect predictors like RVSP might offer greater usefulness. We confirmed that the impact of RVSP is progressive and not limited to patients with the highest baseline values.”

Although Dr. Desai is quick to note that these observational findings require prospective replication, he says they should prompt closer scrutiny of optimal timing of mitral valve repair surgery in this population. “It appears that even mild RVSP elevation — 35 mm Hg or above — might be a marker of early decompensation,” he notes. “As a result, waiting for RVSP to progress to 50 mm Hg or more before offering mitral valve repair could have negative prognostic implications. This demands further study.”

Related Articles

illustration of heart and lungs with text
February 13, 2024
Vital Statistics in Adult Cardiac Surgery, Valve Surgery and Aorta Surgery

Check out our latest volume and outcomes data in these key areas

illustration of heart and lungs with text
May 4, 2023
Vital Stats From Our Heart Failure and Electrophysiology Programs

Our latest volume and outcomes data in two key subspecialty areas

22-HVI-3477523 CQD 650&#215;450
May 1, 2023
Complex Cardiovascular Presentations, Standard-Setting Outcomes: A Photo Essay

Visual snapshots of how we manage challenging cases

illustration of heart and lungs with text
February 24, 2023
Vital Stats in Adult Cardiac Surgery, Valve Surgery and Aorta Surgery

Our latest volume and outcomes data in infographic form

illustration of heart and lungs with text
October 21, 2022
Vital Stats in Adult Cardiac Surgery, Ischemic Heart Disease and Vascular Disease

Our latest volume and outcomes data in infographic form

22-HVI-2731158 CQD Vitals Infographic 1
May 24, 2022
Vital Stats From Our Heart Failure and Electrophysiology Programs (Infographic)

Get a glimpse of our latest volume and outcomes data

Ad